Legal and ethical issues: Pharmaceuticals, medicines...

 

Previous pageNext pagePage 1 of 1


all[17]papers[16]cases[0]news[0]classics[1]
Sort by:
 Date      Most read
Narrow by:
Search within results:
Start searching...
Reset search
Print  |  Email  |  Add to My Folder
My preferred format is HTML  |  Change to PDF

Paper
1.
Direct-to-Consumer Advertising and Its Effect on Prescription Requests
Angela Hausman, Journal of Advertising Research, Vol. 48, No. 1, Mar 2008, pp.42-56
Advertising prescription drugs to consumers is becoming increasingly common and expensive - over $3 billion in 2003 - yet the mechanism by which advertising drives requests for prescription drugs rema ...

Summary | Full Text | More Like This
Read: 9 times
Paper
2.
Public Responses to Direct-to-Consumer Advertising of Prescription Drugs
Sheng Yuan, Journal of Advertising Research, Vol. 48, No. 1, Mar 2008, pp.30-41
In this article, the author has explored the factors that influence the effectiveness of direct-to-consumer (DTC) advertising of prescription drugs. The study was based on a telephone interview with a ...

Summary | Full Text | More Like This
Read: 2 times
Paper
3.
Consumer responses towards non-prescription and prescription drug advertising in the US and Germany: they don't really like it, but they do believe it
Sandra Diehl, Barbara Mueller and Ralf Terlutter, International Journal of Advertising, Vol. 27, No. 1, 2008, pp.99-131
Pharmaceutical advertising has generated considerable interest among both researchers and practitioners. This paper analyses overall attitude and scepticism towards both nonprescription and prescripti ...

Summary | Full Text | More Like This
Read: 57 times
Paper
4.
Direct-to-Consumer Pharmaceutical Advertising: Building and Testing a Model for Advertising Effectiveness
Rick T. Wilson and Brian D. Till, Journal of Advertising Research, Vol. 47, No. 3, Sept 2007, pp.270-282
Using a large-scale database, we present, test, and refine a model for direct-to-consumer (DTC) advertising effectiveness via structural equation modeling. Results suggest that consumers who are great ...

Summary | Full Text | More Like This
Read: 56 times
Paper
5.
The halftime report
Daniel L. Jaffe, The Advertiser, February 2006, pp.56-57
Advertisers faced some serious challenges during the first half of the 109th Congress, including legislative activity relating to marketing food to children, direct-to-consumer prescription drug adver ...

Summary | Full Text | More Like This
Read: 8 times
Paper
6.
Direct-to-consumer prescription drug advertising: understanding its consequences
Jisu Huh and Lee B. Becker, International Journal of Advertising, Vol. 24, No. 4, 2005, pp.441-466
Direct-to-consumer (DTC) prescription drug advertising is one of the fastest-growing advertising categories in the USA and has generated a great deal of controversy among policy makers, physicians and ...

Summary | Full Text | More Like This
Read: 22 times
Paper
7.
Pharmaceutical advertising in the USA: information or influence?
Bruce A Huhmann, Jennifer J Argo and Kellly J Main, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.119-142
While many parts of pharmaceutical advertisements are regulated, each advertisement also contains a promotional component in which the advertiser conveys information to the consumer. The purpose of ...

Summary | Full Text | More Like This
Read: 45 times
Paper
8.
Consumer response to print prescription drug advertising
Scott C. Purvis and Abhilasha Mehta, Journal of Advertising Research, Vol. 43, No. 2, June 2003, pp.194-206
Direct-to-consumer (DTC) prescription drug advertising has grown significantly over the last few years and extended into a variety of health conditions, even as the controversy around it continues. Ho ...

Summary | Full Text | More Like This
Read: 12 times
Paper
9.
Media and message effects on DTC prescription drug print advertising awareness
Martin S. Roth, Journal of Advertising Research, Vol. 43, No. 2, June 2003, pp.180-193
Despite various surveys of consumer attitudes toward direct-to-consumer (DTC) prescription drug advertising, little is known about the effectiveness of specific advertising campaigns. This article com ...

Summary | Full Text | More Like This
Read: 29 times
Paper
10.
Direct-to-consumer advertising for prescription pharmaceuticals: a good idea?
Roderick White, Hot Topics, June 2003
WARC Hot Topics are the essential guide to debates in and around marketing. This paper explores the key issues surrounding DTC pharma ads, with onward links to related papers on WARC and the Web.

Summary | Full Text | More Like This
Read: 16 times
Paper
11.
Healthcare mega-trends in the United States and Germany
Dieter Karczak, ESOMAR, Healthcare Conference, New York, February 2003
Throughout the world health care systems are stressed, and have developed different approaches and answers to solve the problems. This paper describes the upcoming trends and solutions in the healthca ...

Summary | Full Text | More Like This
Read: 18 times
Paper
12.
Orientations to health care reform
Diana MacDonald, Lorne Rothman and Jane Armstrong, ESOMAR, Healthcare Conference, New York, February 2003
This paper describes an approach that allows us to take the findings of a large scale health survey of more than 3,000 Canadians and analyse these findings so as to assess Canadians’ reactions not jus ...

Summary | Full Text | More Like This
Read: 4 times
Paper
13.
Consumer driven prescription drug plans
Donald Falkinburg and James Bologna, ESOMAR, Healthcare Conference, New York, February 2003
Considerable discussion on the rising healthcare and pharmaceutical costs and the future direction of the U.S. healthcare system is routinely heard in political debates and with employers. Employers a ...

Summary | Full Text | More Like This
Read: 4 times
Paper
14.
The public health impact of direct-to-consumer advertising on the United States
Humphrey Taylor and Katherine Binns, ESOMAR, Global Healthcare Conference, Miami, February 2002, pp.49-68
While the United States has pioneered the use of direct-to-consumer advertising (DTCA) of prescription drugs, this topic is being discussed and considered by policymakers in Europe and many other coun ...

Summary | Full Text | More Like This
Read: 6 times
Classic paper - a key, timeless read
15.
Why DTC advertising has failed in the United States and how it can succeed
Michelle Castillo and Renee Hopkins, ESOMAR, Global Healthcare Conference, Miami, February 2002, pp.33-48
Since restrictions on direct-to-consumer (DTC) advertising were loosened in 1997, spending on DTC advertising in the United States has quadrupled. Now the European Union may soon begin testing DTC adv ...

Summary | Full Text | More Like This
Read: 14 times
Paper
16.
Washington Focus: Prescription Drug Advertising: In The Bull's Eye Again
Daniel L. Jaffe, The Advertiser, Aug 1999
Update on the ANA's continuing fight to free prescription drugs advertising from unnecessary regulation.

Summary | Full Text | More Like This
Read: 1 times
Paper
17.
Eagle eye
Ross Denton, Admap, October 1990
A regular column surveying the attempts of the European Commission to regulate advertising. This month, the focus is on pharmaceuticals and tobacco (see also articles by the same author in Admap May 1 ...

Summary | Full Text | More Like This
Read: 0 times


1 Page:




WARC Publications  |  WARC Conferences  |  About Us  |  Links  |  Contact Us  |  Terms & Conditions
© 2008 Copyright and Database Rights owned by WARC

  |    |  
Subjects
SEARCHStart searching...
Start an Advanced Searchall subjectsfind a case studyDigitalProduct CategoriesMarketingConsumersAdvertisingBrandsMediaData